Tilray Brands Posts Record Q1 Revenue and Gross Profit for Fiscal 2027
Tilray Brands reported record first-quarter revenue and gross profit for fiscal 2027, driven by double-digit growth in international cannabis, beverages, and pharmaceutical distribution.
Tilray Brands announced record revenue and gross profit for the first quarter of fiscal 2027, the company said in an earnings release, with gains attributed to double-digit year-over-year growth across its international cannabis, beverage alcohol, and pharmaceutical distribution segments.
The Canadian cannabis and consumer goods company said the results reflect what it described as disciplined execution and category leadership across its global platform. Management framed the quarter as evidence that Tilray's strategy of building scale across multiple business lines is translating into measurable financial improvement.
Read more Artprice 2026 Report Tracks Record Sales in Contemporary Art Market →
International cannabis operations were cited as a key growth driver alongside the beverage segment, which Tilray has expanded aggressively through acquisitions of U.S. craft beer brands in recent years. The pharmaceutical distribution arm, which operates primarily in Europe, also contributed to the record quarter.
The company positioned the first-quarter performance as continued momentum rather than an isolated result, suggesting its diversified model — spanning regulated cannabis markets, mainstream consumer beverages, and European pharma logistics — is gaining traction simultaneously across geographies.
Analysts have watched Tilray closely as one of the few cannabis-adjacent companies to pursue a large-scale diversification strategy while awaiting potential U.S. cannabis regulatory reform. The record gross profit figure indicates improving unit economics, though the company did not break out net income details in the initial release. Continue reading at GlobeNewswire - Earnings Releases And Operating Results.
